Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. It tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.
BörsenkürzelEIKN
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
Geschäftsjahresende- -
Addresse3929 Point Eden Way
Stadt
BörseNASDAQ OMX - NASDAQ BASIC
Land- -
Postleitzahl94545
Telefon
Website
BörsenkürzelEIKN
IPO-datum- -
CEO- -
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten